Arcus Biosciences, Inc.·4

Sep 30, 6:59 PM ET

Azoy Alexander 4

4 · Arcus Biosciences, Inc. · Filed Sep 30, 2025

Insider Transaction Report

Form 4
Period: 2025-09-29
Azoy Alexander
Chief Accounting Officer
Transactions
  • Sale

    Common Stock

    2025-09-29$13.00/sh2,831$36,80327,363 total
Footnotes (1)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 6, 2025.

Documents

1 file
  • 4
    wk-form4_1759273140.xmlPrimary

    FORM 4